Kassel, Germany

Stephanie Herz

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Biontech Rna Pharmaceuticals Gmbh, Tron Translationale Onkologie an Der Universitatsm. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Herz. Retrieved from https://idiyas.com/inventor/stephanie-herz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stephanie Herz: Innovator in Cellular RNA Expression

Introduction

Stephanie Herz is a prominent inventor based in Kasel, Germany. She has made significant contributions to the field of cellular RNA expression, holding two patents that enhance the viability of cells for RNA expression. Her work is pivotal in advancing biotechnological applications.

Latest Patents

Her latest patents focus on a method for cellular RNA expression. The invention relates to expressing RNA in cells and specifically aims to enhance the viability of cells in which RNA is to be expressed. The methods provided involve preventing engagement of the IFN receptor by extracellular IFN and inhibiting intracellular IFN signaling in the cells. This innovative approach allows for the repetitive transfer of RNA into the cells, thereby improving the efficiency of RNA expression.

Career Highlights

Throughout her career, Stephanie has worked with notable organizations such as Tron Translationale Onkologie an Der Universitätsmedizin and BioNTech RNA Pharmaceuticals GmbH. Her experience in these companies has contributed to her expertise in the field of RNA technology.

Collaborations

Stephanie has collaborated with esteemed colleagues, including Ugur Sahin and Tim Beissert. These partnerships have further enriched her research and development efforts in cellular RNA expression.

Conclusion

Stephanie Herz is a trailblazer in the field of cellular RNA expression, with her innovative patents and collaborations paving the way for advancements in biotechnology. Her contributions are essential for the future of RNA applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…